scholarly article | Q13442814 |
P2093 | author name string | J Casals-Stenzel | |
K H Weber | |||
P2860 | cites work | Characterization of peripheral-type benzodiazepine binding sites in brain using [3H]Ro 5-4864 | Q28264829 |
Present concepts on the mechanisms of platelet aggregation | Q40302756 | ||
Background and present status of research on platelet-activating factor (PAF-acether). | Q40312852 | ||
Interaction of benzodiazepines with mouse macrophages | Q41537156 | ||
Autoradiographic localization of "peripheral-type" benzodiazepine binding sites in the rat brain, heart and kidney | Q48531376 | ||
Benzodiazepine receptors on human blood platelets | Q51836725 | ||
Characterization of a peripheral-type benzodiazepine binding site on human circulating lymphocytes. | Q51852159 | ||
Properties of [3H]diazepam binding sites on rat blood platelets | Q51872339 | ||
Properties of [3H] diazepam binding to rat peritoneal mast cells | Q51875358 | ||
Mediators of immune-complex-induced aggregation of polymorphonuclear neutrophils. II. Platelet-activating factor as the effector substance of immune-induced aggregation | Q58831985 | ||
Selective antagonists of benzodiazepines | Q59057876 | ||
Platelet-activating factor induces a platelet-dependent bronchoconstriction unrelated to the formation of prostaglandin derivatives | Q72144140 | ||
Platelet-Activating Factor-Induced Aggregation of Human Platelets Specifically Inhibited by Triazolobenzodiazepines | Q72594997 | ||
THE AGGREGATION OF BLOOD PLATELETS | Q76530970 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 139-146 | |
P577 | publication date | 1987-01-01 | |
P1433 | published in | British Journal of Pharmacology | Q919631 |
P1476 | title | Triazolodiazepines: dissociation of their Paf (platelet activating factor) antagonistic and CNS activity | |
P478 | volume | 90 |
Q46682830 | Effect of WEB 2170 BS, platelet activating factor receptor inhibitor, in the guinea pig model of middle ear inflammation |
Q35756578 | Effect of endothelium on basal and on stimulated accumulation and efflux of cyclic GMP in rat isolated aorta |
Q38627145 | Hetrazepines as antagonists of platelet activating factor |
Q67953472 | Inhibitory effect of oral WEB 2086, a novel selective PAF-acether antagonist, on ex vivo platelet aggregation |
Q41906314 | Interaction of the Paf antagonist WEB 2086 and its hetrazepine analogues with human platelets and endothelial cells |
Q35756710 | Intracellular platelet-activating factor regulates eicosanoid generation in guinea-pig resident peritoneal macrophages |
Q35756479 | Limited interference of specific Paf antagonists with hyper-responsiveness to Paf itself of lungs from actively sensitized guinea-pigs |
Q41662880 | Long time incubation of monocytic U 937 cells with LDL increases specific paf-acether binding and the cellular acetylhydrolase activity |
Q39635714 | PAF antagonists. Their potential therapeutic role in asthma |
Q40524595 | Platelet activating factor antagonists |
Q37885574 | Preclinical and clinical pharmacology of platelet-activating factor receptor antagonists |
Q44472575 | Role of platelet activating factor in triazolobenzodiazepines-induced retrograde amnesia |
Q35755135 | The involvement of platelet activating factor in endotoxin-induced pulmonary platelet recruitment in the guinea-pig |
Q38247605 | The role of platelet activating factor in allergic inflammation |
Q28768533 | The role of platelet activating factor in allergic respiratory disease |
Q36471356 | Thieno-triazolo-1,4-diazepines as antagonists of platelet-activating factor: Present status |
Q40490600 | Treatment of bronchospastic disorders in the 1990s. What does the future hold? |